Toll Free: 1-888-928-9744
Published: Nov, 2014 | Pages:
41 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Zambon Company S.p.A. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Zambon Company S.p.A. - Product Pipeline Review - 2014', provides an overview of the Zambon Company S.p.A.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Zambon Company S.p.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Zambon Company S.p.A. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Zambon Company S.p.A.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Zambon Company S.p.A.'s pipeline products Reasons to buy - Evaluate Zambon Company S.p.A.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Zambon Company S.p.A. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Zambon Company S.p.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Zambon Company S.p.A. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Zambon Company S.p.A. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Zambon Company S.p.A. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Zambon Company S.p.A. Snapshot 5 Zambon Company S.p.A. Overview 5 Key Information 5 Key Facts 5 Zambon Company S.p.A. - Research and Development Overview 6 Key Therapeutic Areas 6 Zambon Company S.p.A. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Zambon Company S.p.A. - Pipeline Products Glance 12 Zambon Company S.p.A. - Late Stage Pipeline Products 12 Pre-Registration Products/Combination Treatment Modalities 12 Zambon Company S.p.A. - Early Stage Pipeline Products 13 Discovery Products/Combination Treatment Modalities 13 Zambon Company S.p.A. - Unknown Stage Pipeline Products 14 Unknown Products/Combination Treatment Modalities 14 Zambon Company S.p.A. - Drug Profiles 15 safinamide 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 ZP-031 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 ZP-037 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 ZP-040 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 ZP-042 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 ZP-049 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 ZP-003 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 ZP-006 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 ZP-008 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 ZP-044 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Zambon Company S.p.A. - Pipeline Analysis 27 Zambon Company S.p.A. - Pipeline Products by Target 27 Zambon Company S.p.A. - Pipeline Products by Route of Administration 28 Zambon Company S.p.A. - Pipeline Products by Molecule Type 29 Zambon Company S.p.A. - Pipeline Products by Mechanism of Action 30 Zambon Company S.p.A. - Recent Pipeline Updates 31 Zambon Company S.p.A. - Dormant Projects 34 Zambon Company S.p.A. - Company Statement 35 Zambon Company S.p.A. - Locations And Subsidiaries 37 Head Office 37 Other Locations & Subsidiaries 37 Appendix 40 Methodology 40 Coverage 40 Secondary Research 40 Primary Research 40 Expert Panel Validation 40 Contact Us 41 Disclaimer 41
List of Tables Zambon Company S.p.A., Key Information 5 Zambon Company S.p.A., Key Facts 5 Zambon Company S.p.A. - Pipeline by Indication, 2014 7 Zambon Company S.p.A. - Pipeline by Stage of Development, 2014 8 Zambon Company S.p.A. - Monotherapy Products in Pipeline, 2014 9 Zambon Company S.p.A. - Partnered Products in Pipeline, 2014 10 Zambon Company S.p.A. - Partnered Products/ Combination Treatment Modalities, 2014 11 Zambon Company S.p.A. - Pre-Registration, 2014 12 Zambon Company S.p.A. - Discovery, 2014 13 Zambon Company S.p.A. - Unknown, 2014 14 Zambon Company S.p.A. - Pipeline by Target, 2014 27 Zambon Company S.p.A. - Pipeline by Route of Administration, 2014 28 Zambon Company S.p.A. - Pipeline by Molecule Type, 2014 29 Zambon Company S.p.A. - Pipeline Products by Mechanism of Action, 2014 30 Zambon Company S.p.A. - Recent Pipeline Updates, 2014 31 Zambon Company S.p.A. - Dormant Developmental Projects,2014 34 Zambon Company S.p.A., Other Locations 37 Zambon Company S.p.A., Subsidiaries 38
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.